Structural Heart Team implants the first two EVOQUE tricuspids transcatheter valve replacements.

Our Structural Heart Team led by cardiologists Jeffrey Tyler, M.D., Brian Kolski, M.D., and Aiden Raney, M.D., successfully implanted the first two EVOQUE tricuspid transcatheter valve replacements at Providence St. Joseph Hospital – the first procedure of its kind in the South Division.

Previously, patients with significant heart failure had no treatment options. The EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR). The EVOQUE system is able to replace the native tricuspid valve, virtually eliminating tricuspid regurgitation in a wide range of patients. Significant improvements are reported by patients, including not feeling short of breath, being able to care for themselves and improved quality of life.

Please join us in recognizing Dr. Tyler and our award-winning Heart & Vascular team for once again leading the charge in cardiovascular health in Orange County.